Stifel Financial Corp Verastem, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.39 - $0.71 $8,151 - $14,839	-20,900 Reduced 9.74%	193,725 $81,000
Q4 2022 Feb 13, 2023	SELL	$0.33 - $10.44 $5,494 - $173,826	-16,650 Reduced 7.2%	214,625 $85,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $759 - $9,207	825 Added 0.36%	231,275 $197,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $12,122 - $21,749	-11,885 Reduced 4.9%	230,450 $267,000
Q1 2022 May 13, 2022	BUY	$1.06 - $2.1 $18,232 - $36,120	17,200 Added 7.64%	242,335 $342,000
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $64,574 - $100,800	-31,500 Reduced 12.27%	225,135 $461,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $44,323 - $71,021	-17,450 Reduced 6.37%	256,635 $790,000
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $7,196 - $13,579	2,800 Added 1.03%	274,085 $1.12 Million
Q1 2021 May 14, 2021	BUY	$1.9 - $2.82 $100,890 - $149,742	53,100 Added 24.34%	271,285 $670,000
Q4 2020 Feb 12, 2021	SELL	$1.15 - $2.4 $16,560 - $34,560	-14,400 Reduced 6.19%	218,185 $465,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $27,855 - $42,159	-25,095 Reduced 9.74%	232,585 $281,000
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $3,549 - $8,820	-2,100 Reduced 0.81%	257,680 $443,000
Q1 2020 May 14, 2020	SELL	$1.26 - $3.38 $12,033 - $32,279	-9,550 Reduced 3.55%	259,780 $693,000
Q4 2019 Feb 13, 2020	SELL	$0.86 - $1.44 $31,762 - $53,183	-36,933 Reduced 12.06%	269,330 $344,000
Q3 2019 Nov 13, 2019	SELL	$1.21 - $1.59 $22,253 - $29,241	-18,391 Reduced 5.66%	306,263 $338,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $12,126 - $30,461	-9,701 Reduced 2.9%	324,654 $483,000
Q1 2019 May 14, 2019	SELL	$2.79 - $4.09 $4,938 - $7,239	-1,770 Reduced 0.53%	334,355 $991,000
Q4 2018 Feb 13, 2019	SELL	$3.23 - $7.01 $27,778 - $60,286	-8,600 Reduced 2.49%	336,125 $1.13 Million
Q3 2018 Nov 13, 2018	SELL	$6.86 - $9.97 $104,272 - $151,544	-15,200 Reduced 4.22%	344,725 $2.49 Million
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $16,689 - $50,242	5,795 Added 1.64%	359,925 $2.47 Million
Q1 2018 May 11, 2018	SELL	$2.92 - $3.81 $5,329 - $6,953	-1,825 Reduced 0.51%	354,130 $1.06 Million
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $44,745 - $72,580	-14,965 Reduced 4.03%	355,955 $1.1 Million
Q3 2017 Nov 13, 2017	BUY	$3.01 - $5.41 $1.12 Million - $2.01 Million	370,920	370,920 $0

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.19 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$254,879
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$106,199
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$15,850
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,702
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account